<List><item><source>MED</source><extId>25244123</extId><pmcid>PMC4171506</pmcid><annotations><annotation><prefix>clinicaltrials.gov; </prefix><exact>NCT01153932</exact><postfix> and NCT01037309) af</postfix><tags><tag><name>NCT01153932</name><uri>http://identifiers.org/clinicaltrials/NCT01153932</uri></tag></tags><id>http://europepmc.org/articles/PMC4171506#europepmc-e2c0a4642cd7521204f7cbba8bfcd4fe</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>ov; NCT01153932 and </prefix><exact>NCT01037309</exact><postfix>) after approval by </postfix><tags><tag><name>NCT01037309</name><uri>http://identifiers.org/clinicaltrials/NCT01037309</uri></tag></tags><id>http://europepmc.org/articles/PMC4171506#europepmc-60accfb6c6fa03f06e1dca6e035ad619</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>(Clinicaltrials.gov </prefix><exact>NCT01037309</exact><postfix>) and biopsies were </postfix><tags><tag><name>NCT01037309</name><uri>http://identifiers.org/clinicaltrials/NCT01037309</uri></tag></tags><id>http://europepmc.org/articles/PMC4171506#europepmc-39e3dfdbce81253f704a129b89221e37</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation></annotations></item></List>